Evidence map›Paper›PMID 38912062›Full record

ArticleFrontiers in oncology2024

Development of esophagogastroduodenoscopy in China: results from the national census in 2013 and 2020.

Siwei Zhou, Zheran Chen, Yunfei Jiao, Zhiyuan Cheng, Ye Gao, Tianjiao Wang, Lei Xin, Rong Wan, Luowei Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Siwei ZhouDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Zheran ChenDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Yunfei JiaoDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Zhiyuan ChengDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Ye GaoDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Tianjiao WangDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Lei XinDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Rong WanDepartment of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Luowei WangDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Given the significant burden of upper digestive diseases, there has been a substantial increase in the utilization of esophagogastroduodenoscopy (EGD) in China from 2012 to 2019. The objective of this study is to investigate the development, practice, and factors influencing the widespread use of EGD during this period. Methods: Two national censuses were conducted among all hospitals in mainland China that perform gastrointestinal endoscopy. These censuses aimed to extract information on the infrastructure, volume, and quality of EGD. The analysis of potential factors influencing EGD practice was based on real-world data from open access sources. Results: From 2012 to 2019, the number of hospitals performing EGD in mainland China increased from 1,518 to 2,265 (1.49-fold) in tertiary hospitals and from 3,633 to 4,097 (1.12-fold) in secondary hospitals, respectively. The national utilization rate of EGD also increased from 1,643.53 to 2,018.06 per 100,000 inhabitants, indicating a 1.23-fold increase. Regions with more endoscopists per 100,000 inhabitants (OR 9.61, Conclusion: Over the past seven years, China has made significant progress in EGD. However, challenges persist in terms of quality and inequality.

Indexed as

Chinaesophagogastroduodenoscopynational censusquality improvementupper gastrointestinal cancer

Identifiers

PMID38912062
PMCPMC11190165

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.